Validating a salmon lice vaccine candidate as a preventive measure against salmon lice at the lab-scale
Publisher : Nofima AS
International Standard Numbers
Printed : 978-82-8296-570-5
Publication type : Nofima’s reports
Series : Nofima rapportserie 32/2018
Year : 2018
FULLTEKST : nofimaas.sharepoint.com/:b:/s/...
ARKIV : http://hdl.handle.net/11250/25...
If you have questions about the publication, you may contact Nofima’s Chief Librarian.
Lepeophtheirus salmonis infections represents an important limitation to sustainable salmon farming today. Vaccines against these ectoparasites have the potential to be cost-effective means of controlling infestation and avoiding the disadvantages of chemical treatments. In this project the vaccine antigen TT-P0 potential against salmon lice was explored at lab-scale. Results showed good potential of TT-P0 vaccine in controlling these ectoparasites in 1st generation by affecting the adult female count and fecundity with greater presumptive potential effect in 2nd lice generation. This is a very important preliminary documentation of TT-P0 vaccine as preventive measure. Further validation is necessary to study long-term effectiveness.